Revision history of "Use of recombinant allergens and antigens in clinical diagnosis" (Q12379)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 March 2024

15 January 2024

11 June 2023

17 February 2023

2 July 2022

  • curprev 19:5719:57, 2 July 2022DG Regio talk contribs 48,783 bytes +29,039 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, pl, sl, lt, lv, bg, hu, ga, sv, et, cs, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, pl, sl, lt, lv, bg, hu, ga, sv, et,

24 June 2022

15 January 2022

14 January 2022

12 December 2021

2 December 2021

  • curprev 08:0408:04, 2 December 2021DG Regio talk contribs 15,127 bytes +1,449 Created claim: summary (P836): Gegenstand des Projekts ist die industrielle Forschung und experimentelle Entwicklung mit Schwerpunkt auf dem Gebiet der In-vitro-Diagnostik, nämlich der Verwendung rekombinanter Allergene und Antigene in Form von BVT-Testprototypen und ELISA-Kits zur qualitativen Diagnose und Überwachung der Therapie allergischer Reaktionen von Patienten und ausgewählten bakteriellen Infektionen. Die daraus resultierenden High-Tech-Produkte werden den Paramete...
  • curprev 08:0408:04, 2 December 2021DG Regio talk contribs 13,678 bytes +136 Changed label, description and/or aliases in de: translated_label

28 November 2021

  • curprev 09:2309:23, 28 November 2021DG Regio talk contribs 13,542 bytes +1,441 Created claim: summary (P836): Le projet porte sur la recherche industrielle et le développement expérimental axés sur le domaine du diagnostic in vitro, à savoir l’utilisation d’allergènes recombinants et d’antigènes sous la forme de prototypes de tests MTD et de kits ELISA pour le diagnostic qualitatif et le suivi du traitement des réactions allergiques des patients et de certaines infections bactériennes. Les produits de haute technologie qui en résulteront seront égaux a...
  • curprev 09:2309:23, 28 November 2021DG Regio talk contribs 12,101 bytes +145 Changed label, description and/or aliases in fr: translated_label

27 December 2020

28 October 2020

22 October 2020

  • curprev 15:2915:29, 22 October 2020DG Regio talk contribs 12,405 bytes +1,376 Created claim: summary (P836): The subject of the project is industrial research and experimental development focused on the field of in vitro diagnostics, namely the use of recombinant allergens and antigens in the form of prototypes of BAT tests and ELISA kits for qualitative diagnostics and monitoring of therapy of allergological reactions of patients and selected bacterial infections. The resulting high-tech products will match the parameters of the world’s top, or excee...
  • curprev 15:2915:29, 22 October 2020DG Regio talk contribs 11,029 bytes −870 Removed claim: summary (P836): The project involves industrial research and experimental development in the area of diagnosis in vitro, specifically to use recombinant allergens and antigens in the form of prototype BAT and ELISA kits for qualitative diagnosis and therapy monitoring for patients and selected bacterial infections. The resulting high-tech products get off the parameters of the world’s peak or go beyond the technical parameters of the known solutions and will...
  • curprev 08:0308:03, 22 October 2020DG Regio talk contribs 11,899 bytes +122 Changed label, description and/or aliases in 1 language: translated_label
  • curprev 08:0308:03, 22 October 2020DG Regio talk contribs 11,777 bytes −122 Changed label, description and/or aliases in 1 language: remove_english_label

22 September 2020

15 July 2020

6 June 2020

25 March 2020

19 March 2020

26 February 2020

  • curprev 07:5307:53, 26 February 2020DG Regio talk contribs 10,623 bytes +870 Created claim: summary (P836): The project involves industrial research and experimental development in the area of diagnosis in vitro, specifically to use recombinant allergens and antigens in the form of prototype BAT and ELISA kits for qualitative diagnosis and therapy monitoring for patients and selected bacterial infections. The resulting high-tech products get off the parameters of the world’s peak or go beyond the technical parameters of the known solutions and will b...

17 February 2020

12 February 2020

6 February 2020

30 January 2020

28 January 2020

16 January 2020

10 January 2020